{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:08:38Z","timestamp":1785600518247,"version":"3.56.0"},"reference-count":56,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>The gene SPG7 codes for the protein paraplegin, a subunit of the m-AAA protease in the inner mitochondrial membrane involved in protein quality control. SPG7 was initially identified as causing autosomal recessive hereditary spastic paraplegia (HSP), with a pure (insidiously progressive bilateral leg weakness and spasticity) and complex (with additional neurologic features including cerebellar signs and optic atrophy) forms. Now identified as one of the most common causes of HSP, SPG7-associated disease has been linked to additional neuro-ophthalmologic features, including isolated dominant optic atrophy, cerebellar eye signs (various forms of nystagmus, dysmetric saccades), progressive external ophthalmoplegia (PEO), and supranuclear vertical palsy. This review describes in detail the various neuro-ophthalmologic presentations of SPG7-associated disease, illustrating the role of mitochondrial dysfunction in the pathophysiology of these different entities. Knowledge of the different manifestations of SPG7-associated disease is crucial for both neurologists and ophthalmologists, and SPG7 should be considered in the work-up of patients presenting with entities such as optic atrophy, PEO, and cerebellar eye signs.<\/jats:p>","DOI":"10.3390\/jpm15100495","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:29:38Z","timestamp":1760599778000},"page":"495","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Neuro-Ophthalmologic Manifestations of SPG7-Associated Disease"],"prefix":"10.3390","volume":"15","author":[{"given":"Ruben","family":"Jauregui","sequence":"first","affiliation":[{"name":"Department of Neurology, NYU Grossman School of Medicine, New York, NY 10017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6356-4450","authenticated-orcid":false,"given":"Christian","family":"Diaz Curbelo","sequence":"additional","affiliation":[{"name":"Department of Neurology, NYU Grossman School of Medicine, New York, NY 10017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3781-7324","authenticated-orcid":false,"given":"Steven L.","family":"Galetta","sequence":"additional","affiliation":[{"name":"Department of Neurology, NYU Grossman School of Medicine, New York, NY 10017, USA"},{"name":"Department of Ophthalmology, NYU Grossman School of Medicine, New York, NY 10017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-5226","authenticated-orcid":false,"given":"Scott N.","family":"Grossman","sequence":"additional","affiliation":[{"name":"Department of Neurology, NYU Grossman School of Medicine, New York, NY 10017, USA"},{"name":"Department of Ophthalmology, NYU Grossman School of Medicine, New York, NY 10017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/MCB.01470-06","article-title":"Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia","volume":"27","author":"Koppen","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ng.544","article-title":"Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28","volume":"42","author":"Lazzaro","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sacco, T., Boda, E., Hoxha, E., Pizzo, R., Cagnoli, C., Brusco, A., and Tempia, F. (2010). Mouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease. BMC Neurosci., 11.","DOI":"10.1186\/1471-2202-11-55"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.200304112","article-title":"Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia","volume":"163","author":"Atorino","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/301930","article-title":"A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3","volume":"63","author":"Cavalcanti","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s00415-021-10507-8","article-title":"Neurophysiological and ophthalmological findings of SPG7-related spastic ataxia: A phenotype study in an Irish cohort","volume":"268","author":"Chen","year":"2021","journal-title":"J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/brain\/awu060","article-title":"Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance","volume":"137","author":"Pfeffer","year":"2014","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.56.4.467","article-title":"Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England","volume":"56","author":"McDermott","year":"2001","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"114203","DOI":"10.1016\/j.expneurol.2022.114203","article-title":"Hereditary spastic paraplegia: Genetic heterogeneity and common pathways","volume":"357","author":"Panza","year":"2022","journal-title":"Exp. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11910-021-01099-x","article-title":"Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia","volume":"21","author":"Saputra","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)81203-9","article-title":"Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease","volume":"93","author":"Casari","year":"1998","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","article-title":"Hereditary spastic paraplegia: Clinical features and pathogenetic mechanisms","volume":"7","author":"Salinas","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/01.wnl.0000201185.91110.15","article-title":"Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia","volume":"66","author":"Elleuch","year":"2006","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nmd.2003.12.004","article-title":"The diagnosis of mitochondrial muscle disease","volume":"14","author":"Taylor","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"ref_16","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Spastic Paraplegia 7. GeneReviews (\u00ae), University of Washington."},{"key":"ref_17","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Uncomplicated (Pure) Hereditary Spastic Paraplegia Overview. GeneReviews (\u00ae), University of Washington."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1399-0004.2012.01896.x","article-title":"SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V","volume":"83","author":"Coto","year":"2013","journal-title":"Clin. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/brain\/awab386","article-title":"Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia","volume":"145","author":"Banneau","year":"2022","journal-title":"Brain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00415-019-09633-1","article-title":"Genotype-phenotype associations in hereditary spastic paraplegia: A systematic review and meta-analysis on 13,570 patients","volume":"268","author":"Torkamandi","year":"2021","journal-title":"J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2679","DOI":"10.1212\/WNL.0000000000007606","article-title":"Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7","volume":"92","author":"Coarelli","year":"2019","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1212\/NXG.0000000000000279","article-title":"Novel genotype-phenotype and MRI correlations in a large cohort of patients with SPG7 mutations","volume":"4","author":"Hewamadduma","year":"2018","journal-title":"Neurol. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00415-014-7432-6","article-title":"Early-onset optic neuropathy as initial clinical presentation in SPG7","volume":"261","author":"Marcotulli","year":"2014","journal-title":"J. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101400","DOI":"10.1016\/j.ajoc.2022.101400","article-title":"A novel homozygous variant in the SPG7 gene presenting with childhood optic nerve atrophy","volume":"26","author":"Eriksen","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1212\/NXG.0000000000000428","article-title":"Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy","volume":"6","author":"Charif","year":"2020","journal-title":"Neurol. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/WNO.0000000000002039","article-title":"Spastic Paraplegia Type 7-Associated Optic Neuropathy: A Case Series","volume":"44","author":"Bell","year":"2024","journal-title":"J. Neuroophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Jauregui, R., Abreu, N.J., Golan, S., Panarelli, J.F., Sigireddi, M., Nayak, G.K., Gold, D.M., Rucker, J.C., Galetta, S.L., and Grossman, S.N. (2023). Neuro-Ophthalmologic Variability in Presentation of Genetically Confirmed Wolfram Syndrome: A Case Series and Review. Brain Sci., 13.","DOI":"10.3390\/brainsci13071030"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajo.2005.03.017","article-title":"Hereditary optic neuropathies: From the mitochondria to the optic nerve","volume":"140","author":"Newman","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.200906084","article-title":"Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1","volume":"187","author":"Ehses","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.201308006","article-title":"The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission","volume":"204","author":"Anand","year":"2014","journal-title":"J. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/brain\/awae324","article-title":"Clinical and genetic landscape of optic atrophy in 826 families: Insights from 50 nuclear genes","volume":"148","author":"Zheng","year":"2024","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies\u2014Disease mechanisms and therapeutic strategies","volume":"30","author":"Griffiths","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awn269","article-title":"Visual system involvement in patients with Friedreich\u2019s ataxia","volume":"132","author":"Fortuna","year":"2009","journal-title":"Brain"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/awr323","article-title":"The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy \u2018plus\u2019 phenotype","volume":"135","author":"Rouzier","year":"2012","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.0000000000001369","article-title":"SPG7 mutations are a common cause of undiagnosed ataxia","volume":"84","author":"Pfeffer","year":"2015","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/WNP.0000000000000579","article-title":"Eye Movement Disorders and the Cerebellum","volume":"36","author":"Shemesh","year":"2019","journal-title":"J. Clin. Neurophysiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kheradmand, A., and Zee, D.S. (2011). Cerebellum and ocular motor control. Front. Neurol., 2.","DOI":"10.3389\/fneur.2011.00053"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jns.2017.01.033","article-title":"Acquired pendular nystagmus","volume":"375","author":"Kang","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/mdc3.13991","article-title":"Periodic Alternating Nystagmus, Ataxia, and Spasticity: A Unique Presentation of Spastic Paraplegia 7-Related Hereditary Spastic Paraplegia","volume":"11","author":"Hickman","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/WNO.0000000000001739","article-title":"Treatment of Periodic Alternating Nystagmus as a Consequence of Ataxia-Telangiectasia","volume":"44","author":"Jauregui","year":"2024","journal-title":"J. Neuroophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-821751-1.00018-X","article-title":"Progressive external ophthalmoplegia","volume":"194","author":"Hirano","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.med.59.053006.104646","article-title":"Inherited mitochondrial diseases of DNA replication","volume":"59","author":"Copeland","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/01.wnl.0000266667.91074.fe","article-title":"A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation","volume":"69","author":"Warnecke","year":"2007","journal-title":"Neurology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/acn3.50907","article-title":"Slowed vertical saccades as a hallmark of hereditary spastic paraplegia type 7","volume":"6","author":"Milenkovic","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_45","unstructured":"Feroze, K.B., and Patel, B.C. (2023). Parinaud Syndrome. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102043","DOI":"10.1016\/j.mito.2025.102043","article-title":"Cell-specific mitochondrial response in progressive supranuclear palsy","volume":"84","author":"Sackmann","year":"2025","journal-title":"Mitochondrion"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0197-0186(01)00126-7","article-title":"Mitochondrial dysfunction in progressive supranuclear palsy","volume":"40","author":"Albers","year":"2002","journal-title":"Neurochem. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"25050","DOI":"10.3390\/ijms161025050","article-title":"Abnormal Paraplegin Expression in Swollen Neurites, \u03c4- and \u03b1-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation","volume":"16","author":"Thal","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.10278","article-title":"Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia","volume":"52","author":"Lamantea","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.49.1.239","article-title":"Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease","volume":"49","author":"Fadic","year":"1997","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/90058","article-title":"Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria","volume":"28","author":"Spelbrink","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/WNO.0000000000002089","article-title":"Optic Neuropathy Associated with POLG Mutations: A Case Series and Literature Review","volume":"44","author":"Reitinger","year":"2024","journal-title":"J. Neuroophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gim.2012.180","article-title":"Genotypic classification of patients with Wolfram syndrome: Insights into the natural history of the disease and correlation with phenotype","volume":"15","author":"Cleries","year":"2013","journal-title":"Genet. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Rigoli, L., Caruso, V., Salzano, G., and Lombardo, F. (2022). Wolfram Syndrome 1: From Genetics to Therapy. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19063225"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3892\/br.2017.987","article-title":"Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene","volume":"7","author":"Colavito","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.25723","article-title":"ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy","volume":"88","author":"Caporali","year":"2020","journal-title":"Ann. Neurol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/10\/495\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:50:05Z","timestamp":1760601005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/10\/495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jpm15100495"],"URL":"https:\/\/doi.org\/10.3390\/jpm15100495","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}